Dendritic cell-targeting chemokines inhibit colorectal cancer progression
Aim: Recent progress in cancer immunotherapy has shown its promise and prompted researchers to develop novel therapeutic strategies. Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating adaptive anti-tumor immunity, therefore a promising target for cancer treatment....
Saved in:
Main Authors: | Pengkun Yuan (Author), Yunyi Zhou (Author), Zhixue Wang (Author), Liming Gui (Author), Bin Ma (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
by: Naofumi Mukaida, et al.
Published: (2014) -
Allogenic mouse cell vaccine inhibits lung cancer progression by inhibiting angiogenesis
by: Jun Zhao, et al.
Published: (2021) -
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis
by: Sarah Low, et al.
Published: (2020) -
Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells
by: Yu Gan, et al.
Published: (2023) -
The Inflammatory Chemokine CCL5 and Cancer Progression
by: Donatella Aldinucci, et al.
Published: (2014)